Growth Metrics

Mannkind (MNKD) Current Deferred Revenue (2014 - 2026)

Mannkind (MNKD) reported Current Deferred Revenue of $11.5 million for Q1 2026, down 1.97% year-over-year from $11.8 million in Q1 2025, and down 24.83% on a QoQ basis from $15.3 million in Q4 2025.

Mannkind (MNKD) has 13 years of Current Deferred Revenue data on file, last reported at $11.5 million in Q1 2026.

  • Quarterly Current Deferred Revenue fell 1.97% year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (down 1.97% YoY) and the FY2025 annual result came in at $15.3 million, up 23.57% from the prior year.
  • Current Deferred Revenue slipped to $11.5 million in Q1 2026 per MNKD's latest filing, from $15.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $78.9 million in Q4 2023 and bottomed at $1.3 million in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $10.1 million (2025), against an average of $19.1 million.
  • The widest annual swing landed in 2022, when Current Deferred Revenue tumbled 94.95%; it then jumped 5829.61% in 2023.
  • Tracing MNKD's Current Deferred Revenue over 5 years: stood at $63.6 million in 2022, then climbed by 24.09% to $78.9 million in 2023, then sank by 84.27% to $12.4 million in 2024, then gained by 23.57% to $15.3 million in 2025, then fell by 24.83% to $11.5 million in 2026.
  • Per Business Quant, the three latest MNKD Current Deferred Revenue figures stand at $11.5 million (Q1 2026), $15.3 million (Q4 2025), and $10.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.53 Mn
Dec 31, 2025 15.33 Mn
Sep 30, 2025 10.12 Mn
Jun 30, 2025 10.95 Mn
Mar 31, 2025 11.76 Mn
Dec 31, 2024 12.41 Mn
Sep 30, 2024 6.52 Mn
Jun 30, 2024 7.42 Mn
Mar 31, 2024 7.60 Mn
Dec 31, 2023 78.88 Mn
Sep 30, 2023 3.67 Mn
Jun 30, 2023 3.49 Mn
Mar 31, 2023 77.50 Mn
Dec 31, 2022 63.57 Mn
Sep 30, 2022 1.79 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 1.31 Mn
Dec 31, 2021 20.37 Mn
Sep 30, 2021 14.02 Mn
Jun 30, 2021 20.13 Mn
Mar 31, 2021 25.88 Mn
Dec 31, 2020 34.94 Mn
Sep 30, 2020 28.87 Mn
Jun 30, 2020 32.18 Mn
Mar 31, 2020 30.84 Mn
Dec 31, 2019 40.85 Mn
Sep 30, 2019 32.21 Mn
Jun 30, 2019 32.37 Mn
Mar 31, 2019 32.38 Mn
Dec 31, 2018 47.57 Mn
Sep 30, 2018 3.60 Mn
Jun 30, 2018 2.69 Mn
Mar 31, 2018 2.30 Mn
Dec 31, 2017 750,000.00
Sep 30, 2017 3.02 Mn
Jun 30, 2017 2.59 Mn
Mar 31, 2017 1.84 Mn
Dec 31, 2016 1.00 Mn
Sep 30, 2016 2.01 Mn
Jun 30, 2016 26.88 Mn
Mar 31, 2016 17.68 Mn
Dec 31, 2015 17.50 Mn
Sep 30, 2015 17.47 Mn
Jun 30, 2015 13.40 Mn
Mar 31, 2015 7.05 Mn
Dec 31, 2014 196.97 Mn
Sep 30, 2014 150.00 Mn